🇺🇸 FDA
Patent

US 11401332

Proteolytically cleavable chimeric polypeptides and methods of use thereof

granted A61KA61K2039/505A61K2239/28

Quick answer

US patent 11401332 (Proteolytically cleavable chimeric polypeptides and methods of use thereof) held by The Regents of the University of California expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2039/505, A61K2239/28, A61K39/39558, A61K40/11